PFE
Pfizer Inc
27.70$
+0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.5% | +8.1% | -0.5% | +2.1% | -23.3% | +1.2% | +95.2% | +23.4% | -40.6% | +6.8% | -1.6% | |
| – | -1.1% | +21.3% | -1.1% | +1.5% | -21.1% | -6.7% | +192.4% | +11.1% | -23.6% | -25.4% | -14.8% | |
| – | -1.7% | +3.3% | -0.3% | +2.4% | -24.2% | +4.7% | +56.9% | +32.5% | -51.1% | +37.9% | +5.2% | |
| – | -7.7% | +2.2% | -2.5% | +4.2% | +5.0% | +12.3% | +47.2% | -17.4% | -7.4% | +1.5% | +11.5% | |
| – | +6.5% | -0.6% | +0.4% | +0.6% | +2.5% | -18.5% | +9.0% | +1.6% | +1.8% | +3.2% | +19.4% | |
| – | +0.6% | +0.9% | -1.0% | -0.1% | -5.9% | -1.2% | +25.4% | -5.9% | +2.1% | +1.3% | +12.7% | |
| – | -5.2% | +7.4% | +0.8% | +6.2% | -50.9% | +21.0% | +128.9% | +80.6% | -85.9% | +211.5% | -6.3% | |
| – | -11.8% | -1.1% | +7.1% | +3.6% | +19.5% | -7.9% | -10.9% | -4.1% | +78.4% | +39.9% | -13.6% | |
| – | -26.8% | -6.8% | +47.3% | -3.4% | -3.4% | -38.7% | +245.5% | +42.9% | -97.0% | +658.3% | -6.3% | |
| – | -36.2% | -43.6% | -906.4% | – | -12.5% | -40.1% | +400.5% | +79.7% | -133.5% | – | – | |
| – | -23.3% | +3.6% | +195.3% | -47.7% | +45.9% | -43.7% | +141.8% | +41.6% | -93.2% | +276.0% | -3.1% | |
| – | -19.9% | -0.2% | +29.8% | -1.3% | -3.7% | -30.2% | +133.8% | +33.2% | -76.7% | +89.7% | -16.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.